Dow Jones Today: Stock Indexes Shake Off US Government Shutdown, End Higher for 4th Straight Session; Dow, S&P 500 Set Fresh Records

U.S. stock indexes, including the Dow and S&P 500, closed at new record highs for a fourth consecutive session, largely shrugging off a federal government shutdown and an unexpected 32,000 private-sector job loss in September, demonstrating historical market resilience to such macro events. Key corporate movers included Nike, up over 6% on strong sales; Lithium Americas, which surged 23% after the U.S. government took a 5% stake and provided a significant loan for its Nevada mining project; and AES, which soared nearly 17% on reports of a $38 billion takeover by BlackRock's GIP, partly driven by its AI data center power contracts. Intel also gained 7% on potential talks to add AMD as a foundry customer, while the pharmaceutical sector saw broad gains following Pfizer's drug pricing deal with the White House, and analysts raised 2024 AI infrastructure spending forecasts to $490 billion, signaling continued tech sector investment.

Analysis

Major U.S. stock indexes achieved new record highs, demonstrating significant resilience by closing up for a fourth consecutive session despite negative macroeconomic signals. The market absorbed a U.S. government shutdown and a surprising ADP report indicating a loss of 32,000 private-sector jobs against expectations of a 45,000 gain. This divergence underscores a market prioritizing company-specific catalysts over historically transient political disruptions and select weak data points. Key drivers were predominantly found in corporate events and M&A activity. AES Corp (AES) shares soared nearly 17% on a reported $38 billion takeover offer from BlackRock's GIP, a deal highlighting the high value placed on infrastructure assets supporting AI data centers. Similarly, Berkshire Hathaway is reportedly nearing a $10 billion deal for Occidental Petroleum's (OXY) chemical unit, signaling a significant capital deployment by the conglomerate. Government policy directly fueled gains in the pharmaceutical sector, with Pfizer (PFE) rising 7% after a pricing deal with the White House, which in turn lifted peers like Eli Lilly (LLY) and AstraZeneca (AZN) by approximately 8% and 10% respectively. In critical minerals, Lithium Americas (LAC) surged 23% after the U.S. government took a 5% stake and provided a $2.26 billion loan for its Nevada project. The technology sector saw Intel (INTC) jump 7% on news of potential foundry talks with AMD, while a Citi forecast upgrade for 2024 AI infrastructure spending to $490 billion reinforced bullish sentiment for suppliers like Nvidia (NVDA). In contrast, company-specific headwinds were also evident, with DocuSign (DOCU) falling another 4% on competitive threats from OpenAI, and Nike (NKE), despite a 6% gain from a surprise sales increase, cautioning about a $1.5 billion tariff impact.

Key Decisions for Investors

• Consider the M&A catalysts in the energy and infrastructure sectors, as the potential premium valuation for AES and Berkshire's large-scale investment in OXY's assets signal strong institutional conviction.
• Re-evaluate positions in the pharmaceutical sector, as the broad rally following Pfizer's government deal suggests a significant de-risking event related to U.S. drug pricing policy.
• Monitor companies directly benefiting from government strategic initiatives, such as Lithium Americas, where direct federal investment and loans can dramatically alter a company's financial and operational trajectory.
• Maintain exposure to the AI infrastructure theme, reinforced by Intel's potential foundry deal and raised capex forecasts, but remain vigilant of specific competitive risks as illustrated by DocuSign's sharp decline.
• While Nike's turnaround shows positive signs with its 1% sales growth, it is prudent to weigh this against its explicit warnings of a holiday sales slowdown and a significant $1.5 billion tariff headwind.